McIlwain Matthew S 13D and 13G filings for Nautilus Biotechnology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2021-08-25 8:58 pm Purchase | 2021-06-09 | 13D | Nautilus Biotechnology, Inc. NAUT | McIlwain Matthew S | 6,368,136 5.130% | 6,368,136 (New Position) | Filing |